Asaf Alimardanov - Concepedia

Author

Asaf Alimardanov

National Center for Advancing Translational Sciences

Also Known As

A. ALIMARDANOV, A. Alimardanov, A. Alimardanov et al., Alimardanov, A., Asaf Alimardanov, Asaf R Alimardanov, Asaf R. Alimardanov

Publications

644

Citations

H-Index

Concepts

All Affiliations

National Center for Advancing Translational Sciences National Institutes of Health Case Western Reserve University University of Toledo The University of Texas Health Science Center at San Antonio

About

Asaf Alimardanov is an author at National Center for Advancing Translational Sciences specializing in organic chemistry, engineering, and chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	6	6	320
2	Medicine	5	5	115
3	Natural Sciences	4	4	284
4	Biochemistry	2	2	46
5	Allergy	1	1	13

Asaf Alimardanov

Publications

620

Citations

H-Index

Page 1

	Year	Citations
Use of “Homeopathic” Ligand‐Free Palladium as Catalyst for Aryl‐Aryl Coupling Reactions Asaf Alimardanov, Lizette Schmieder‐van de Vondervoort, André H. M. de Vries, Advanced Synthesis & Catalysis Chemical EngineeringCross-coupling ReactionEngineeringNatural SciencesDiversity-oriented Synthesis	2004	205
An Efficient and Stereoselective Synthesis of Xerulin <i>via</i> Pd-Catalyzed Cross Coupling and Lactonization Featuring (<i>E</i>)-Iodobromoethylene as a Novel Two-Carbon Synthon Ei‐ichi Negishi, Asaf Alimardanov, Caiding Xu Organic Letters	1999	75
Synthesis of α-iodo-α,β-unsaturated ketones by the reaction of α-silyl-α,β-unsaturated ketones with ICl or IClAlCl3 Asaf Alimardanov, Ei‐ichi Negishi Tetrahedron Letters	1999	37
Discovery of (2<i>S</i>,4<i>R</i>)-1-(2-Aminoacetyl)-4-benzamidopyrrolidine-2-carboxylic Acid Hydrochloride (GAP-134)<sup>13</sup>, an Orally Active Small Molecule Gap-Junction Modifier for the Treatment of Atrial Fibrillation John A. Butera, Bjarne Due Larsen, James K. Hennan, Journal of Medicinal Chemistry -4-Benzamidopyrrolidine-2-carboxylic Acid HydrochloridePharmacotherapyCardiac ConductionChemical BiologyMolecular Pharmacology	2009	36
Practical Enantioselective Synthesis of a 3-Aryl-3-trifluoromethyl-2-aminopropanol Derivative Asaf Alimardanov, Antonia A. Nikitenko, Terrence J. Connolly, Organic Process Research & Development Single IsomerAsymmetric CatalysisDerivativesEngineeringNatural Sciences	2009	33
CB <sub>1</sub> R and iNOS are distinct players promoting pulmonary fibrosis in Hermansky–Pudlak syndrome Joshua K. Park, Charles N. Zawatsky, Nathan J. Coffey, Clinical and Translational Medicine	2021	33
The Platform Vector Gene Therapies Project: Increasing the Efficiency of Adeno-Associated Virus Gene Therapy Clinical Trial Startup Philip J. Brooks, Elizabeth A. Ottinger, Deanna Portero, Human Gene Therapy Gene TherapiesEngineeringIn Vivo Gene TherapyPathologyVirology	2020	30
The Fungal Cyp51 Inhibitor VT-1129 Is Efficacious in an Experimental Model of Cryptococcal Meningitis Nathan P. Wiederhold, Laura K. Najvar, Edward P. Garvey, Antimicrobial Agents and Chemotherapy	2018	26
Detailed Protocol for the Novel and Scalable Viral Vector Upstream Process for AAV Gene Therapy Manufacturing Nagarathinam Selvaraj, Chao-Kuei Wang, Brian Bowser, Human Gene Therapy Viral ReplicationEngineeringIn Vivo Gene TherapySynthetic VirologyImmunology	2021	26
<i>In Vivo</i> Efficacy of VT-1129 against Experimental Cryptococcal Meningitis with the Use of a Loading Dose-Maintenance Dose Administration Strategy Nathan P. Wiederhold, Xin Xu, Amy Wang, Antimicrobial Agents and Chemotherapy	2018	25

Page 1